Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Finished Goods (2018 - 2019)

Historic Finished Goods for Niagen Bioscience (NAGE) over the last 2 years, with Q4 2019 value amounting to $4.9 million.

  • Niagen Bioscience's Finished Goods rose 9906.12% to $4.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $4.9 million, marking a year-over-year increase of 9906.12%. This contributed to the annual value of $4.9 million for FY2019, which is 9906.12% up from last year.
  • Latest data reveals that Niagen Bioscience reported Finished Goods of $4.9 million as of Q4 2019, which was up 9906.12% from $2.4 million recorded in Q4 2018.
  • Niagen Bioscience's Finished Goods' 5-year high stood at $4.9 million during Q4 2019, with a 5-year trough of $2.4 million in Q4 2018.